World Library  
Flag as Inappropriate
Email this Article

Arsenic trioxide

Article Id: WHEBN0002067748
Reproduction Date:

Title: Arsenic trioxide  
Author: World Heritage Encyclopedia
Language: English
Subject: Arsenic, Mineral industry of Peru, Sesquioxides, Arsenolite, Bezoar
Publisher: World Heritage Encyclopedia

Arsenic trioxide

Arsenic trioxide
Arsenic trioxide
Ball-and-stick model of the As4O6 molecule
     As3+      O2−
CAS number  YesY
ChemSpider  YesY
EC number
RTECS number CG3325000
ATC code L01
Jmol-3D images Image 1
Molecular formula As
Molar mass 197.841 g/mol
Appearance White solid
Density 3.74 g/cm3
Melting point 312.2 °C (594.0 °F; 585.3 K)
Boiling point 465 °C (869 °F; 738 K)
Solubility in water 20 g/L (25 °C)
see text
Solubility soluble in dilute acids and alkalies, practically insoluble in organic solvents [2]
Acidity (pKa) 9.2
Crystal structure cubic (α)<180 °C
monoclinic (β) >180 °C
Molecular shape See text
Dipole moment Zero
Std molar
? J.K−1.mol−1
Std enthalpy of
−657.4 kJ/mol
Protein binding 75% bound
MSDS External MSDS
EU classification Very toxic (T+)
Carc. Cat. 1
Dangerous for the
environment (N)
R-phrases R45, R28, R34,
S-phrases S53, S45, S60,
NFPA 704
LD50 14.6 mg/kg (rat, oral)
Related compounds
Other anions Arsenic trisulfide
Other cations Phosphorus trioxide
Antimony trioxide
Related compounds Arsenic pentoxide
Arsenous acid
Supplementary data page
Structure and
n, εr, etc.
Phase behaviour
Solid, liquid, gas
Spectral data UV, IR, NMR, MS
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
 N   YesY/N?)

Arsenic trioxide is an formula As
. This commercially important tonnes are produced annually.[3] Many applications are controversial given the high toxicity of arsenic compounds.

Production and occurrence

historical arsenic mine Sankt Blasen, Austria

Arsenic trioxide can be generated via routine processing of arsenic compounds including the oxidation (combustion) of arsenic and arsenic-containing minerals in air. Illustrative is the roasting of orpiment, a typical arsenic sulfide ore.

2 As
+ 9 O
→ 2 As
+ 6 SO

Most arsenic oxide is, however, obtained as a volatile by-product of the processing of other ores. For example, arsenopyrite, a common impurity in gold- and copper-containing ores, liberates arsenic trioxide upon heating in air. The processing of such minerals has led to numerous cases of poisonings.[4] Only in China are arsenic ores intentionally mined.[3]

In the laboratory, it is prepared by hydrolysis of arsenic trichloride:[5]

2 AsCl3 + 3 H2O → As2O3 + 6 HCl

occurs naturally as two minerals, arsenolite (cubic) and claudetite (monoclinic). Both are relatively rare secondary minerals found in oxidation zones of As-rich ore deposits.

Properties and reactions

Arsenic trioxide is an amphoteric oxide, and its aqueous solutions are weakly acidic. Thus, it dissolves readily in alkaline solutions to give arsenites. It is less soluble in acids, although it will dissolve in hydrochloric acid.[6]

With anhydrous HF and HCl, it gives AsF3 and the trichloride:[5]

As2O3 + 6 HX → 2 AsX3 + 3 H2O (X = F, Cl)

Only with strong oxidizing agents such as ozone, hydrogen peroxide, and nitric acid does it yield arsenic pentoxide, As
or its corresponding acid:[5]

2 HNO3 + As2O3 + 2 H2O → 2 H3AsO4 + N2O3

In terms of its resistance to oxidation, arsenic trioxide differs from phosphorus trioxide, which readily combusts to phosphorus pentoxide.

Reduction gives elemental arsenic or arsine (AsH
) depending on conditions:[5]

As2O3 + 6 Zn + 12 HNO3 → 2 AsH3 + 6 Zn(NO3)2 + 3 H2O

This reaction is used in the Marsh test.


In the liquid and gas phase below 800 °C, arsenic trioxide has the formula As
and is isostructural with P
. Above 800 °C As
significantly dissociates into molecular As
, which adopts the same structure as N
. Three forms (polymorphs) are known in the solid state: a high temperature ( > 110 °C) cubic As
, containing molecular As
, and two related polymeric forms.[7] The polymers, which both crystallize as monoclinic crystals, feature sheets of pyramidal AsO
units that share O atoms.[8]

claudetite I
claudetite II


Large scale applications include its use as a precursor to forestry products, in colorless glass production, and in electronics.[3] Being the main compound of arsenic, the trioxide is the precursor to elemental arsenic, arsenic alloys, and Roxarsone) and pharmaceuticals (Neosalvarsan), are derived from arsenic trioxide. Bulk arsenic-based compounds sodium arsenite and sodium cacodylate are derived from the trioxide.

A variety of applications exploit arsenic's toxicity, including the use of the oxide as a wood preservative. Copper arsenates, which are derived from arsenic trioxide, are used on a large scale as a wood preservative in the US and Malaysia, but such materials are banned in many parts of the world. This practice remains controversial.[3] In combination with copper(II) acetate arsenic trioxide gives the vibrant pigment known as Paris green used in paints and as a rodenticide. This application has been discontinued.

Medical applications

Despite the well known toxicity of arsenic, arsenic trioxide has long been of biomedical interest, dating to traditional Chinese medicine, where it is known as Pi Shuang and is still used to treat cancer and other conditions,[9] and to homeopathy, where it is called arsenicum album. Some discredited patent medicines, e.g., Fowler's solution, contained derivatives of arsenic oxide.[10]

In the 1970s Chinese researcher Zhang TingDong and colleagues investigated the potential use of the traditionally used Chinese medicine arsenic trioxide to treat acute promyelocytic leukemia (APL).[11] Building on his work, research both in China and the West eventually led to the development of the drug Rrisenox by PolaRx Biopharmaceuticals, Inc through NDA, which was approved for leukemia treatment by the US FDA in 2000 and subsequently marketed and sold by Cell Therapeutics, Inc., before being acquired by Cephalon.[12] Arsenic trioxide, under the tradename Trisenox (manufacturer: Cephalon acquired by Teva), is a chemotheraputic agent approved by the US FDA for the treatment of acute promyelocytic leukemia that is unresponsive to "first line" agents, namely all-trans retinoic acid (ATRA). It has been shown that arsenic trioxide induces cancer cells to undergo apoptosis. Due to the toxic nature of arsenic, this drug carries significant risks. Use as a cytostatic in the treatment of refractory promyelocytic (M3) subtype of acute myeloid leukemia.[13][14] The combination therapy of arsenic trioxide and all-trans retinoic acid (ATRA) has been approved by the U.S. Food and Drug Administration (FDA) for treatment of certain leukemias.[15] University of Hong Kong developed a liquid form of arsenic trioxide that can be administered orally.[16]


Arsenic trioxide is readily absorbed by the digestive system: toxic effects are also well known upon inhalation or upon skin contact. Elimination is rapid at first (half-life of 1–2 days), by methylation to monomethylarsonic acid and dimethylarsonic acid, and excretion in the urine, but a certain amount (30–40% in the case of repeated exposure) is incorporated into the bones, muscles, skin, hair and nails (all tissues rich in keratin) and eliminated over a period of weeks or months.

The first symptoms of acute arsenic poisoning by ingestion are digestive problems: vomiting, abdominal pains, diarrhea often accompanied by bleeding. Sub-lethal doses can lead to convulsions, cardiovascular problems, inflammation of the liver and kidneys and abnormalities in the coagulation of the blood. These are followed by the appearance of characteristic white lines (Mees' lines) on the nails and by hair loss. Lower doses lead to liver and kidney problems and to changes in the pigmentation of the skin. Even dilute solutions of arsenic trioxide are dangerous on contact with the eyes.

The poisonous properties are legendary and the subject of an extensive literature.[17][18][19]

Chronic arsenic poisoning is known as arsenicosis. This disorder affects workers in smelters, in populations whose drinking water contains high levels of arsenic (0.3–0.4 ppm), and in patients treated for long periods with arsenic-based pharmaceuticals. Similarly, studies on workers exposed in copper foundries in the U.S., Japan and Sweden indicate a risk of lung cancer 6–10 times higher for the most exposed workers compared with the general population. Long-term ingestion of arsenic trioxide either in drinking water or as a medical treatment can lead to skin cancer. Reproductive problems (high incidence of miscarriage, low birth weight, congenital deformations) have also been indicated in one study of women exposed to arsenic trioxide dust as employees or neighbours of a copper foundry.

In Austria, there lived the so-called "arsenic eaters of Styria", who ingested doses far beyond the lethal dose of arsenic trioxide without any apparent harm. Arsenic is thought to enable strenuous work at high altitudes, e.g. in the Alps.[20][21][22][23]

In the U.S., the breathing zone air is 0.010 mg/m3.

Environmental problems

Smelting and related ore processing often general arsenic trioxide, which poses a severe risks to the environment. For example, the Giant Mine in Canada processed substantial amounts of arsenopyrite-contaminated gold ores.


  1. ^ Shakhashiri, B. Z. "Chemical of the Week: Arsenic". University of Wisconsin-Madison Chemistry Dept. 
  2. ^ Patnaik, P. (2002). Handbook of Inorganic Chemicals. McGraw-Hill.  
  3. ^ a b c d Grund, S. C.; Hanusch, K.; Wolf, H. U. (2005), "Arsenic and Arsenic Compounds",  
  4. ^ "Giant Mine – Northwest Territories Region – Indian and Northern Affairs Canada". Retrieved 2007-08-28. 
  5. ^ a b c d Handbook of Preparative Inorganic Chemistry, 2nd Ed. Edited by G. Brauer, Academic Press, 1963, NY.
  6. ^ Greenwood, N. N.; & Earnshaw, A. (1997). Chemistry of the Elements (2nd Edn.), Oxford:Butterworth-Heinemann. ISBN 0-7506-3365-4.
  7. ^ Wells A.F. Structural Inorganic Chemistry. 5th. London, England: Oxford University Press, 1984. Print. ISBN 0-19-855370-6
  8. ^ Holleman, A. F.; Wiberg, E. (2001). Inorganic Chemistry. San Diego: Academic Press.  
  9. ^ Gielen, M.; Tiekink, E. R. (2005). Metallotherapeutic Drugs and Metal-Based Diagnostic Agents. Wiley. p. 298.  
  10. ^ Gibaud, S.; Jaouen, G. (2010). "Arsenic-Based Drugs: From Fowler's Solution to Modern Anticancer Chemotherapy". Topics in Organometallic Chemistry. Topics in Organometallic Chemistry 32: 1–20.  
  11. ^ Rao Y, Li R, Zhang D (June 2013). "A drug from poison: how the therapeutic effect of arsenic trioxide on acute promyelocytic leukemia was discovered". Sci China Life Sci 56 (6): 495–502.  
  12. ^ Bian Z, Chen S, Cheng C, Wang J, Xiao H, Qin H (2012). "Developing new drugs from annals of Chinese medicine". Acta Pharmaceutica Sinica B 2: 1.  
  13. ^ Soignet, S. L.; Frankel, S. R.; Douer, D.; Tallman, M. S.; Kantarjian, H.; Calleja, E.; Stone, R. M.; Kalaycio, M.; Scheinberg, D. A. et al. (2001). "United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia" (pdf). Journal of Clinical Oncology 19 (18): 3852–3860.  
  14. ^ Antman, K. H. (2001). "Introduction: The history of arsenic trioxide in cancer therapy" (pdf). Oncologist 6 (Supplement 2): 1–2.  
  15. ^ Zhu, J.; Chen, Z.; Lallemand-Breitenbach, V.; De Thé, H. (2002). "How acute promyelocytic leukaemia revived arsenic". Nature Reviews Cancer 2 (9): 705–714.  
  16. ^ Au, W.-Y.; Kumana, C. R.; Kou, M.; Mak, R.; Chan, G. C.; Lam, C.-W.; Kwong, Y.-L. (2003). "Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia" (pdf). Blood 102 (1): 407–408.  
  17. ^ "Stanton v Benzler 9716830". U.S. 9th Circuit Court of Appeals. 1998-06-17. Retrieved 2008-06-09. (...) convicted by a jury of first degree murder for poisoning her ex-husband. Her ex-husband's body was found with traces of arsenic trioxide in it. 
  18. ^ Emsley, J. (2006). "Arsenic". The Elements of Murder: A History of Poison.  
  19. ^  
  20. ^ "Arsenic Eaters". New York Times. July 26, 1885. 
  21. ^ Allesch, R. M. (1959). Arsenik. Seine Geschichte in Österreich. Archiv für vaterländische Geschichte und Topographie 54. Klagenfurt: Kleinmayr. 
  22. ^ Przygoda, G.; Feldmann, J.; Cullen, W. R. (2001). "The arsenic eaters of Styria: a different picture of people who were chronically exposed to arsenic". Applied Organometallic Chemistry 15 (6): 457–462.  
  23. ^ Whorton, J. C. (2010). The Arsenic Century.  

External links

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.